Bruker Corporation
NASDAQ:BRKRMedical - Devices
-$1.07 today
- Market cap
- $9.66B
- Beta
- 1.30
- P/E (TTM)
- -718.1
- EPS (TTM)
- -$0.08
- Dividend yield
- 0.37%
Volume 1.73M
Average 2.41M
BRKR Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Bruker CorporationNASDAQ: BRKR
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses growth accelerates
Q2 FY2026 operating expenses of $481.3M rose 39.1% year over year, ahead of the +2.0% change in trailing-twelve-month operating expenses. Sequentially, it rose 39.8% from the prior quarter. Over 3 fiscal years it compounded at +15.4% a year.
Context
- Operating expenses amounted to 39.0% of revenue in FY2025, down 2.4 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +39.1% holds above the trailing-twelve-month pace of +2.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 1.34B USD
- Year-over-year change
- -3.9%
- 4-year CAGR
- +13.9%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.34B | -3.9% |
| FY2024 | 2024-12-31 | 1.4B | +29.7% |
| FY2023 | 2023-12-31 | 1.08B | +23.3% |
| FY2022 | 2022-12-31 | 873M | +9.6% |
| FY2021 | 2021-12-31 | 796.3M | — |
Operating Expenses vs competitors
How BRKR compares with its peers on the latest reported figures
- BRKR's LTM Jun 2026 operating expenses of $1.51B is the 5th highest of the 11 companies compared; the peer median is $1.2B.
- Its year-over-year change of +2.0% is the 7th highest of 11, against a peer median of +3.4%.
- Operating expenses amounts to 43.1% of revenue for BRKR, versus a peer median of 39.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.11B | +15.5% | -1.1% | 23.5% | |
| LTM Sep 2026 | $9.79B | +2.9% | +4.4% | 38.2% | |
| LTM Jul 2026 | $2.32B | +7.9% | +0.9% | 31.5% | |
| LTM Jul 2026 | $1.99B | +108.4% | +3.2% | 42.8% | |
| LTM Jun 2026 | $1.51B | +2.0% | +15.4% | 43.1% | |
| LTM Jun 2026 | $1.24B | +6.1% | +4.5% | 29.9% | |
| LTM Jul 2026 | $1.16B | +3.9% | +5.8% | 39.8% | |
| LTM Jun 2026 | $1.11B | -1.5% | -0.2% | 42.8% | |
| LTM Jun 2026 | $766.43M | -6.1% | -3.3% | 36.5% | |
| LTM Sep 2026 | $566.75M | -17.3% | +5.1% | 46.1% | |
| LTM Mar 2026 | $222.12M | -73.8% | +19.5% | 138.8% | |
| Peer median (excluding BRKR) | $1.2B | +3.4% | +3.8% | 39.0% | |
Competitors are the stored peer set for BRKR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.42B | 2.53B | 2.96B | 3.37B | 3.44B |
| Cost of Revenue | 1.21B | 1.23B | 1.45B | 1.72B | 1.86B |
| Gross Profit | 1.21B | 1.31B | 1.51B | 1.65B | 1.58B |
| Gross Margin | 50.0% | 51.6% | 51.0% | 49.0% | 45.9% |
| Research & Development | 220.8M | 235.9M | 294.8M | 376.5M | 395.2M |
| Selling, General & Admin | 562.3M | 607.4M | 729.4M | 893.8M | 946.5M |
| Operating Expenses | 796.3M | 873M | 1.08B | 1.4B | 1.34B |
| Depreciation & Amortization | 89.1M | 88.7M | 114.9M | 183.8M | 220.3M |
| EBITDA | 497M | 518.7M | 675.5M | 438.6M | 302.6M |
| EBITDA Margin | 20.6% | 20.5% | 22.8% | 13.0% | 8.8% |
| Operating Income | 413.3M | 432.7M | 436.9M | 253.1M | 236M |
| Operating Margin | 17.1% | 17.1% | 14.7% | 7.5% | 6.9% |
| Interest Income | 900K | 2.8M | 7.5M | 9.3M | 14.8M |
| Interest Expense | 14.3M | 16.1M | 16.4M | 47.9M | 60.3M |
| Other Income / Expenses | (19.7M) | (17.8M) | 109.3M | (47.9M) | (215M) |
| Income Before Tax | 393.6M | 414.9M | 546.2M | 205.2M | 21M |
| Pre-Tax Margin | 16.3% | 16.4% | 18.4% | 6.1% | 0.6% |
| Income Tax Expense | 113M | 116.4M | 117.7M | 91.4M | 29.3M |
| Net Income | 277.1M | 296.6M | 427.2M | 113.1M | (8.6M) |
| Net Margin | 11.5% | 11.7% | 14.4% | 3.4% | -0.3% |
| EPS (Basic) | 1.83 | 2.00 | 2.92 | 0.76 | (0.15) |
| EPS (Diluted) | 1.81 | 1.99 | 2.90 | 0.76 | (0.15) |
| Weighted Avg Shares | 151.4M | 148.6M | 146.4M | 149M | 151.8M |
| Weighted Avg Shares (Diluted) | 152.9M | 149.4M | 147.2M | 149.5M | 151.8M |
Bruker Corporation
NASDAQ:BRKR
Intrinsic Alpha fair value
Locked
Current Price
$63.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.